Abstract:Two novel complexes were prepared and showed remarkable anticancer activity for HeLa cells. Fluorescence and UV–vis spectroscopy showed that these complexes interacted with DNA through the embedding methods. Traditional platinum (Pt)‐based drugs have limited use in cancer treatment because of their toxicity, which generates the need for new Pt complexes with effective anticancer activity. Two potent prospective anticancer small molecule drug complexes, PtLCl (1) and PdLCl (2) (L:4‐[2,2′:6′,2′‐terpyridin‐4′‐yl]phenol), were synthesized via a low‐temperature solvothermal method. The structures of the complexes are characterized by a four‐coordinated rhombus plane, according to single‐crystal X‐ray diffraction studies. The complexes 1 and 2 were further characterized using several techniques including powder X‐ray diffraction, infrared spectroscopy, and cyclic voltammetry. Cytotoxicity was assessed using flow cytometry and morphological observations of HeLa cells. The findings demonstrate that both complexes were highly effective at inducing cell death, and the tumor inhibition rate of 1 was greater than that of 2, with total tumor inhibition of 92.3% and 72.3%, respectively, after 24 h. In addition, fluorescence and UV–vis spectroscopy showed that these complexes interacted with DNA through the embedding methods. The four‐coordinated planar structure and π–π stacking could prevent DNA transfer and replication, which has the potential for more effective cancer cell eradication through intercalation. Therefore, these two complexes are promising candidates for the development of new Pt‐ and Pd‐based anticancer drugs.

Two wheel-shaped Pr(III) and Er(III) complexes with long flexible ligand: Crystal structure, fluorescence and anticancer studies

Two new lanthanide complexes with 5-(Pyrazol-1-yl)nicotinic acid: Structures and their anti-cancer properties

Synthesis, Characterization and DNA Binding of the Complexes of Rare Earth with Phenanthroline and Demethylcantharate

Synthesis, Characterization, Dna-Binding Studies of Rare Earth Complexes with N-Phenyl Norcantharidin Acylamide Acid

Lanthanide (III) complexes (Ln = Er and Yb) based on polypyridyl ligand: Synthesis, crystal structure, DNA-binding activity and interaction with human serum protein in vitro

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Synthesis of 1,10-phenanthroline-erbium(Ⅲ) complex and its biological activity

Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-α-amino acid conjugates

Three water-soluble acylhydrazone tetranuclear transition metal complexes: Crystal structures, DNA/BSA interactions and cytotoxicity studies

DNA binding studies and in-vitro anticancer studies of novel lanthanide complexes

Synthesis and anticancer activities of novel Pt (II) and Pd (II) complexes with 4‐(2,2′:6′,2′′‐terpyridin‐4′‐yl)phenol as ligand

Pyridine hydrazyl thiazole metal complexes: Synthesis, crystal structure, antibacterial and antitumor activity

Two Water-Soluble Copper(ii) Complexes: Synthesis, Characterization, DNA Cleavage, Protein Binding Activities and in Vitro Anticancer Activity Studies.

Synthesis, Characterization, and Biological Activities of Two Cu(II) and Zn(II) Complexes with One Polyquinoline Ligand.

Four cyclometalated Ir(iii) complexes and insights into their luminescence, cytotoxicity and DNA/BSA binding performance

Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds

Synthesis, characterization, and cytotoxicity of Pt (II) and Pd (II) complexes with 2-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline as ligand

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

In vitro and in vivo anticancer activity of novel Rh(III) and Pd(II) complexes with pyrazolopyrimidine derivatives

Rhodium(I) Complexes Containing the N^N^N-Chelating Ligand: Synthesis, Structure, and Biological Activity

Synthesis, structural characterization and antitumor activity of six rare earth metal complexes with 8-hydroxyquinoline derivatives